Table 3.
Viral clearance time and Ct value differences in different neutralizing antibody levels.
| Groups accortding to NAb titre (Median [IQR]) | ||||
|---|---|---|---|---|
| High | Medium | Low | p value | |
| Breakthrough cases | ||||
| Viral clearance time (days) | 19[16-23.25] | 17.5[14-20.25] | 17.5[11.5-19.75] | 0.454 |
| Ct value Max-Min | 13[9.5-18] | 19.5[14.5-21.5] | 22[18.5-24.75] | 0.047 |
| Ct value Max-Min/Viral clearance time | 0.69[0.45-1.07] | 1.11[0.74-1.55] | 1.38[1.01-1.89] | 0.033 |
| Unvaccinated-infected cases | ||||
| Viral clearance time (days) | 18[12-24.25] | 11.5[9.5-15] | 13[10.75-18.25] | 0.267 |
| Ct value Max-Min | 19.5[14.75-26.25] | 21.5[15.25-24] | 20.5[19-23.75] | 0.929 |
| Ct value Max-Min/Viral clearance time | 1.26[0.61-3.02] | 1.64[1.21-2.50] | 1.73[1.08-2] | 0.605 |
Note: Ct denotes cycle threshold.